Yong Ki Min Selected Research

fluphenazine-N-mustard

12/2009

Calmodulin inhibition contributes to sensitize TRAIL-induced apoptosis in human lung cancer H1299 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yong Ki Min Research Topics

Disease

8	Neoplasms (Cancer) 01/2022 - 07/2007
6	Osteoporosis 07/2016 - 05/2008
4	Bone Resorption 03/2015 - 09/2008
3	Breast Neoplasms (Breast Cancer) 04/2008 - 12/2005
2	Inflammation (Inflammations) 03/2020 - 02/2020
2	Vitamin D Deficiency 07/2016 - 09/2015
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2016
1	Postmenopausal Osteoporosis 09/2015
1	Hip Fractures (Intertrochanteric Fractures) 03/2015
1	Hypogonadism (Hypergonadotropic Hypogonadism) 12/2014
1	Acromegaly 12/2014
1	Hyperprolactinemia 12/2014
1	Osteomalacia 03/2013
1	Pain (Aches) 03/2013
1	Musculoskeletal Pain 03/2013
1	Hypophosphatemia 03/2013
1	Musculoskeletal Diseases (Musculoskeletal Disease) 03/2013
1	Parathyroid Neoplasms (Parathyroid Neoplasm) 02/2012
1	Pheochromocytoma 01/2012
1	Sarcoma (Soft Tissue Sarcoma) 07/2010
1	Lung Neoplasms (Lung Cancer) 12/2009
1	Carcinogenesis 12/2006
1	Hyperglycemia 12/2005

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 02/2012 - 12/2005
3	Denosumab FDA Link 07/2016 - 03/2015
3	LigandsIBA 03/2015 - 02/2009
2	lysophosphatidic acidIBA 03/2020 - 02/2020
2	25-hydroxyvitamin DIBA 07/2016 - 09/2015
2	hydroxide ionIBA 07/2016 - 09/2015
2	Glucose (Dextrose)FDA LinkGeneric 12/2014 - 12/2005
2	licochalcone AIBA 04/2012 - 09/2008
2	Pharmaceutical PreparationsIBA 07/2010 - 05/2008
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 07/2010 - 09/2009
2	Estrogens (Estrogen)FDA Link 04/2008 - 12/2005
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 12/2006 - 12/2005
1	Calcibiotic Root Canal SealerIBA 01/2022
1	Cetuximab (Erbitux)FDA Link 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Cyclin-Dependent Kinase 4IBA 01/2022
1	quemliclustatIBA 01/2022
1	palbociclibIBA 01/2022
1	Adenosine (Adenocard)FDA LinkGeneric 01/2022
1	atezolizumabIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	NivolumabIBA 01/2021
1	pembrolizumabIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 03/2020
1	Vitamin D FDA LinkGeneric 07/2016
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 06/2016
1	Thyroid HormonesIBA 06/2016
1	Ibandronic Acid (Boniva)FDA Link 09/2015
1	Cholecalciferol (Vitamin D3)FDA Link 09/2015
1	Monoclonal AntibodiesIBA 03/2015
1	Diphosphonates (Bisphosphonates)IBA 03/2015
1	Growth Hormone (Somatotropin)IBA 12/2014
1	Octreotide (Sandostatin)FDA LinkGeneric 12/2014
1	Antineoplastic Agents (Antineoplastics)IBA 05/2014
1	adefovirIBA 03/2013
1	Phosphates (Orthophosphate)IBA 03/2013
1	Calcitriol (Calcijex)FDA LinkGeneric 03/2013
1	adefovir dipivoxil (Hepsera)FDA Link 03/2013
1	MetanephrineIBA 01/2012
1	CatecholaminesIBA 01/2012
1	euphorbiasteroidIBA 07/2010
1	Caspase 8 (Caspase-8)IBA 12/2009
1	Inhibitor of Apoptosis ProteinsIBA 12/2009
1	fluphenazine-N-mustardIBA 12/2009
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 12/2009
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 12/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2009
1	LignansIBA 02/2009
1	Transcription Factors (Transcription Factor)IBA 02/2009
1	Macrophage Colony-Stimulating FactorIBA 02/2009
1	NF-kappa B (NF-kB)IBA 02/2009
1	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 02/2009
1	Anabolic AgentsIBA 11/2008
1	Emodin (Archin)IBA 05/2008
1	PeroxiredoxinsIBA 04/2008
1	Protein Isoforms (Isoforms)IBA 04/2008
1	3- (2- (pyrrolidin- 1- yl)ethoxy)- 1,10b- dihydro- (1,2,4)triazolo(1,5- c)quinazolin- 5(6H)- oneIBA 07/2007
1	2-hydroxyestradiolIBA 12/2005
1	2-MethoxyestradiolIBA 12/2005
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2005
1	Estrogen ReceptorsIBA 12/2005
1	4-hydroxyestradiolIBA 12/2005

Therapy/Procedure

3	Therapeutics 01/2021 - 03/2013
2	Immunotherapy 01/2022 - 01/2021
1	Islets of Langerhans Transplantation 12/2005